Varnika Roy, Ph.D., works as a Senior Director Head of Analytical and Materials Science in MSAT – Pharma Supply Chain at GSK. Prior to this, Varnika had several roles in GSK Vaccines Development-Head of Global Bioassays Development and CMC Team Lead for early and late stage CMC teams for mRNA and subunit recombinant protein vaccine development and took products through Phases 1-3 of clinical development. Before joining GSK, Varnika was a Senior Scientist at MedImmune (Astrazeneca) in the Cell Culture and Fermentation Sciences department. There, Dr. Roy designed cell culture processes for expression and scale-up of antibody-type molecules using CHO and microbial processes. She also led a CMC team for the development of an antibody-drug conjugate and multiple academic-industrial collaborations. Varnika received her Ph.D. in Molecular and Cell Biology at the University of Maryland College Park. Varnika has multiple lead author publications and was the past chair of the American Chemical Society’s Biochemical Technology (BIOT) Division.